CoChat

Melanoma cells become resistant to NK‐cell‐mediated killing when exposed to NK‐cell numbers compatible with NK‐cell infiltration in the tumor

Balsamo, Mirna, Vermi, William, Parodi, Monica, Pietra, Gabriella, Manzini, Claudia, Queirolo, Paola, Lonardi, Silvia, Augugliaro, Raffaella, Moretta, Alessandro, Facchetti, Fabio, Moretta, Lorenzo, Mingari, Maria Cristina, Vitale, Massimo · 2012 · European Journal of Immunology
Cited by 110

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

During the past few years, a number of studies reported that different melanoma cell lines could be extensively lysed in vitro by IL‐2‐activated NK cells at appropriate effector/target ratios. Here, we show, by histological evaluation of different melanoma lesions, that NK/target‐cell ratios compatible with those allowing efficient melanoma cell killing in vitro are hardly reached at the tumor site. We then investigated the outcome of cocultures established at low NK/melanoma cell ratios. After initial NK‐mediated lysis, residual melanoma cells acquired resistance to IL‐2‐activated NK cells. This reflected primarily an increased expression, on melanoma cells, of classical and nonclassical HLA class I molecules, accompanied by a partial downregulation of NKG 2 D‐ligands, and was dependent on NK‐mediated IFN‐γ release. Consistently, melanoma lesions showed a higher HLA class I expression on tumor cells that were proximal to infiltrating NK cells. In long‐term cocultures, the “protective phenotype” acquired by melanoma cells was lost over time. However, this phenomenon was counteracted by downregulation of relevant activating receptors in cocultured NK cells. Analysis of different NK‐cell‐activating cytokines indicated that IL‐15 can partially overcome this novel tumor escape mechanism suggesting that IL‐15, rather than IL‐2, may be eligible for NK‐cell‐based immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201142179

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 110

Metadata

Authors
Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., Moretta, L., Mingari, M. C., & Vitale, M.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2012-05-25
Volume
42
Issue
7
Pages
1833-1842
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W1560838147
Cited by
110
References
5
FWCI
2.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.